Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies
Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies
Recruiting · NCT06034275 · Registry updated 2024-11-15Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies | B-cell acute lymphoblastic leukemia, B-cell neoplasm, Burkitt lymphoma, DNA Virus Infections, Epstein-Barr virus infection, Hemic and Lymphatic Diseases, Herpesviridae infectious disease, Infections, Neoplasms by Histologic Type, Neoplasms by Site, Tumor Virus Infections, acute myeloid leukemia, bone marrow disorder, hematologic disorder, hematopoietic and lymphoid system neoplasm, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, myeloid leukemia, neoplasm, viral infectious disease | Recruiting | Phase 1 | 2024-11-15 | NCT06034275 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Vincerx Pharma, Inc. | 1 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Fred Hutchinson Cancer Center | Seattle | United States | 250 |
| MD Anderson Cancer Center | Houston | United States | 589 |
| TriStar Bone Marrow Transplant | Nashville | United States | 8 |
| University of Alabama at Birmingham | Birmingham | United States | 193 |
| University of Cincinnati | Cincinnati | United States | 55 |